Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma by BCLC Stage”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01900002
What this trial is testing

Sorafenib Tosylate and Yttrium Y 90 Glass Microspheres in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Who this might be right for
Advanced Adult Hepatocellular CarcinomaBCLC Stage C Hepatocellular CarcinomaRecurrent Adult Hepatocellular Carcinoma+8 more
M.D. Anderson Cancer Center 40
Early research (Phase 1)Study completedNCT01666756
What this trial is testing

Chinese Herbal Formulation PHY906 and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerAdvanced Adult Hepatocellular Carcinoma+2 more
City of Hope Medical Center 18
Large-scale testing (Phase 3)UnknownNCT04909866
What this trial is testing

The Efficacy and Safety of TACE, Lenvatinib and Camrelizumab in the Treatment of BCLC Stage B/C Hepatocellular Carcinoma: a Single-arm, Single-center, Open-label Study

Who this might be right for
Hepatocellular Carcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 40
Large-scale testing (Phase 3)Study completedNCT02856126
What this trial is testing

HAIC Plus Sorafenib Versus TACE Plus Sorafenibfor Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 214
Not applicableUnknownNCT03652896
What this trial is testing

Anatomy-based Resection or Margin-based Resection for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma by BCLC Stage
Huazhong University of Science and Technology 60
Testing effectiveness (Phase 2)UnknownNCT04814030
What this trial is testing

Transarterial Infusion of PD-1 Antibody Plus TACE-HAIC for Unresectable HCC: a Single-arm, Phase 2 Clinical Trial

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 80
Testing effectiveness (Phase 2)WithdrawnNCT05327738
What this trial is testing

Yttrium Y 90 Glass Microspheres, Atezolizumab, and Cabozantinib for the Treatment of Unresectable or Locally Advanced Hepatocellular Carcinoma

Who this might be right for
BCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular CarcinomaLocally Advanced Hepatocellular Carcinoma+2 more
OHSU Knight Cancer Institute
Early research (Phase 1)Active Not RecruitingNCT04605731
What this trial is testing

Durvalumab and Tremelimumab After Radioembolization for the Treatment of Unresectable, Locally Advanced Liver Cancer

Who this might be right for
BCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular CarcinomaLocally Advanced Hepatocellular Carcinoma+7 more
City of Hope Medical Center 25
Not applicableLooking for participantsNCT07268131
What this trial is testing

TITAN-HCC: Neoadjuvant and Adjuvant QL1706 With TACE in Resectable Hepatocellular Carcinoma Beyond Milan Criteria

Who this might be right for
Hepatocellular Carcinoma (HCC)
Fudan University 30
Not applicableUnknownNCT01764438
What this trial is testing

Utility Study of Primovist-MRI on HCC Staging

Who this might be right for
Hepatocellular Carcinoma
Inha University Hospital 174
Testing effectiveness (Phase 2)UnknownNCT04483284
What this trial is testing

Study of TACE Combined With Camrelizumab in the Treatment of HCC Patients

Who this might be right for
Hepatocellular Carcinoma
Shanghai Zhongshan Hospital 28
Not applicableStudy completedNCT07368530
What this trial is testing

Using Machine Learning to Identify Responders to TACE or HAIC for uHCC

Who this might be right for
Unresectable Hepatocellular Carcinoma (HCC)BCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular Carcinoma
First Affiliated Hospital, Sun Yat-Sen University 3,000
Testing effectiveness (Phase 2)Study completedNCT00910572
What this trial is testing

Radioembolization With Yttrium-90 Microspheres for Intermediate or Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 60
Not applicableStudy completedNCT02088775
What this trial is testing

PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerMetastatic Extrahepatic Bile Duct Cancer+4 more
Fox Chase Cancer Center 44
Very early researchEnded earlyNCT04777708
What this trial is testing

BO-112 and Pembrolizumab for the Treatment of PD-1/PD-L1 Refractory Liver Cancer

Who this might be right for
Advanced Hepatocellular CarcinomaBCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular Carcinoma+1 more
Jonsson Comprehensive Cancer Center 1
Testing effectiveness (Phase 2)Looking for participantsNCT06741020
What this trial is testing

Hepatic Arterial Infusion Chemotherapy and Immunotherapy for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
Zhejiang Cancer Hospital 10
Large-scale testing (Phase 3)Active Not RecruitingNCT05883644
What this trial is testing

Durvalumab and Tremelimumab as First Line Treatment in Participants With Advanced Hepatocellular Carcinoma (HCC)

Who this might be right for
Advanced Hepatocellular Carcinoma
AstraZeneca 111
Testing effectiveness (Phase 2)Study completedNCT04000737
What this trial is testing

YIV-906 (Formerly PHY906/KD018) With Sorafenib in HBV(+) Hepatocellular Carcinoma (HCC)

Who this might be right for
Advanced Hepatocellular Carcinoma
Yiviva Inc. 62
Not applicableLooking for participantsNCT04777942
What this trial is testing

Neo-TACE-HAIC for High-risk BCLC A Stage HCC (NeoconceptA)

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 320
Testing effectiveness (Phase 2)UnknownNCT02672488
What this trial is testing

Metformin Plus Sorafenib for Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 82
Next Page